Optimizing acne therapy with unique vehicles

Journal of Drugs in Dermatology

Volumn 9, Issue 5, 2010, Pages

  Kircik, Leon ^a,b   Friedman, Adam ^c  

^a INDIANA UNIVERSITY   (United States)

^b Physicians Skin Care PLLC   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYL PEROXIDE; BENZOYL PEROXIDE PLUS CLINDAMYCIN; BETA CYCLODEXTRIN; DRUG VEHICLE; NICOTINAMIDE; RETINOIC ACID; DERMATOLOGICAL AGENT;

ACNE VULGARIS; ARTICLE; BLISTER; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; ENCAPSULATION; ERYTHEMA; HUMAN; PATIENT COMPLIANCE; SKIN FUNCTION; SKIN IRRITATION; STRATUM CORNEUM; INTRADERMAL DRUG ADMINISTRATION; REVIEW; VEHICLES;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; BENZOYL PEROXIDE; DERMATOLOGIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; TRETINOIN; VEHICLES;

EID: 77954529998     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Huang X, Tanojo H, Lenn J, et al. VersaFoam: A novel vehicle for the delivery of topical corticosteroids. J Am Acad Dermatol. 2005;53:S26-38. (Pubitemid 40828179)
2. Panchagnula R. Transdermal delivery of drugs. Indian J Pharmacol. 1997;29:140-156. (Pubitemid 27296932)
3. Walters KA and Roberts MS. The structure and function of skin. In: K.A. Walters, ed. Dermatological and Transdermal Formulations. New York: Marcel Dekker; 2002:1-39.
4. Williams AC and Barry BW. Skin absorbing enhancers. Crit Rev Ther Drug Carrier Syst. 1992;9:305-353.
5. Roberts MS and Cross SE. Skin transport. In: Walters KA, ed. Dermatological and Transdermal Formulations. New York: Marcel Dekker; 2002:89-195.
6. Schaefer H, Redelmeier TE, Nohynek GJ. Pharmacokinetics and topical applications of drugs. In: Freedberg IM, Eisen AZ, Wolff H, et al, eds. Fitzpatrick's Dermatology in General Medicine. Vol 2. New York:McGraw-Hill; 2003:2313-2318.
7. Matsuzaki K, Imaoka T, Asano M, et al. Development of a model membrane system using stratum corneum lipids for estimation of drug skin permeability. Chem Pharm Bull. 1993;41:575-579. (Pubitemid 23144549)
8. Embil K and Nacht S. The Microsponge® Delivery System: A topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of active. J Microencapsulation. 1996;13(5):575-588. (Pubitemid 26283810)
9. Saxena S, Nacht S. Polymeric Porous Delivery Systems: Poyltrap® and Microsponge®. Delivery System Handbook for Personal Care and Cosmetic Products. In MR Rosen, ed. Technology, Applications and Formulations. New York: William Andrew Publishing; 2005:334-351.
10. Bucks D, Sarpotdar P, Yu K, et al. J Drugs Dermatol. 2009;8(7):634-638.
11. Gold MH. A new, once-daily, optimized, fixed combination of clindamycin phosphate 1.2% and low-concentration benzoyl peroxide 2.5% gel for the treatment of moderate-to-severe acne. J Clin Aesth Dermatol. 2009;2(5):44-48.
12. Kligman AM, Leyden JJ, Stewart R. New uses for benzoyl peroxide: A broad spectrum antimicrobial agent. Int J Dermatol. 1977;16(5):413-417 (Pubitemid 8142815)
13. Kligman AM, Fulton JE, Plewig G. Topical vitamin A acid in acne vulgaris. Arch Dermatol. 1969;99:469-476.
14. Lavker RM and Leyden JJ. An ultrastructural study of the effects of topical tretinoin on microcomedones. Clin Ther. 1994;14:,773-780.
15. Bernerd F, Demarchez M, Ortonne JP, et al. Sequence of morphological events during topical application of retinoic acid on the rhino mouse skin. Br J Dermatol. 1991;125:419-425J.
16. Nyirady J, Bennett M L, Advancement of tretinoin through the microsphere technology. Cosmet Dermatol. 2001,14:22-24.
17. Dow G. A Novel Aqueous Metronidazole 1% Gel with Hydrosolubilizing Agents (HAS-3™). Cutis. 2006;77(4 Suppl):18-26. (Pubitemid 43723534)
18. Draelos Z. Assessment of skin barrier function in rosacea patients with a novel 1% metronidazole gel. J Drugs Dermatol. 2005;4(5):557-562.
19. Thiboutot DM, Willmer J, Sharata H, et al. Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris. Clin Pharmacokinet. 2007;46(8):697-712. (Pubitemid 47204855)
20. Hadgraft J. Passive enhancement strategies in topical and transdermal drug delivery. Int J Pharm. 1999;184(1):1-6. (Pubitemid 29308990)
21. Davis RH, Parker WL, Murdoch DP. Aloe vera as a biologically active vehicle for hydrocortisone acetate. J Am Pod Assoc. 1991;81(1):1-9.
22. Burnett B Mitchell CM. Antimicrobial activity of iodoquinol 1%-hydrocortisone acetate 2% gel against ciclopirox and clotrimazole. Cutis. 2008;82(4):273-80.